1 / 42

USC Monthly Seminar Series Physical Sciences in Oncology Center Los Angeles, CA May 17, 2013

“Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer”. USC Monthly Seminar Series Physical Sciences in Oncology Center Los Angeles, CA May 17, 2013. Dr. Larry Smarr

steel-bridges
Télécharger la présentation

USC Monthly Seminar Series Physical Sciences in Oncology Center Los Angeles, CA May 17, 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” USC Monthly Seminar Series Physical Sciences in Oncology Center Los Angeles, CA May 17, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E. Gruber Professor, Dept. of Computer Science and Engineering Jacobs School of Engineering, UCSD http://lsmarr.calit2.net

  2. Abstract Colon Cancer is the most common cancer among Inflammatory Bowel Disease (IBD) patients and IBD is one of the three leading high-risk factors for Colon Cancer. In 2012 it was found, by using genetic sequencing of the gut microbiome, that Fusobacteria sequences were enriched in colorectal carcinomas (CRC). To explore this possible link between inflammation, gut microbes, and colon cancer I have turned my own body into a "genomic observatory." I have been tracking over 100 blood/stool biomarkers in my own body every few months for the last five years, with a focus on immune variables. Using key biomarkers and imaging technologies I diagnosed myself as having late-onset Crohn's Disease, one of the two forms of IBD. Besides obtaining one million SNPs of my human genome, I have collaborated with the J. Craig Venter Institute to metagenomically sequence my gut microbiome at three different times during a period of high inflammation. My microbiome was compared with 50 other subjects, sequenced by the NIH Human Microbiome Project--35 healthy and the remainer with IBD. I discovered that at the height of my inflammation (CRP~30), I had 8% relative abundance of Fusobacteria, 40x healthy subjects. Following antibiotic/corticosteroid therapy the Fusobacteria were reduced 90-fold. The next step is to move to high-throughput integrated personal "omics" to refine the host-microbiome dynamics. With these new tools of computationally-intensive omics, there is a hope that we will gain new insights into the pathogenisis of CRC.

  3. Visualizing Time Series of 150 LS Blood and Stool Variables, Each Over 5-10 Years Calit2 64 megapixel VROOM

  4. Only One of My Blood Measurements Was Far Out of Range--Indicating Chronic Inflammation 27x Upper Limit Episodic Peaks in Inflammation Followed by Spontaneous Drops Antibiotics Antibiotics Normal Range<1 mg/L Normal Complex Reactive Protein (CRP) is a Blood Biomarker for Detecting Presence of Inflammation

  5. Lactoferrin is an Antibacteria Glycoprotein Shed from WBC Neutrophils Into Stool Sample 124x Healthy Upper Limit Typical Lactoferrin Value for Active IBD Normal Range <7.3 µg/mL Antibiotics Antibiotics Lactoferrin Sequesters Iron

  6. Colonoscopy Images Show Inflamed Pseudopolyps in 6 inches of Sigmoid Colon May 2011 Dec 2010

  7. Confirming the IBD (Crohn’s) Hypothesis:Finding the “Smoking Gun” with MRI Imaging I Obtained the MRI Slices From UCSD Medical Services and Converted to Interactive 3D Working With Calit2 Staff & DeskVOX Software Liver Transverse Colon Small Intestine Descending Colon MRI Jan 2012 Cross Section Diseased Sigmoid Colon Major Kink Sigmoid Colon Threading Iliac Arteries

  8. MRE Reveals Inflammation in 6 Inches of Sigmoid ColonThickness 15cm – 5x Normal Thickness “Long segment wall thickening in the proximal and mid portions of the sigmoid colon, extending over a segment of approximately 16 cm, with suggestion of intramural sinus tracts. Edema in the sigmoid mesentery and engorgement of the regional vasa recta.” – MRI report DeskVOX 3D Image Crohn's disease affects the thickness of the intestinal wall. Having Crohn's disease that affects your colon increases your risk of colon cancer. Clinical MRI Slice Program

  9. An MRI Shows Sigmoid Colon Wall ThickenedIndicating Probable Diagnosis of Crohn’s Disease

  10. Why Did I Have an Autoimmune Disease like IBD? Despite decades of research, the etiology of Crohn's disease remains unknown. Its pathogenesis may involve a complex interplay between host genetics, immune dysfunction, and microbial or environmental factors. --The Role of Microbes in Crohn's Disease So I Set Out to Quantify All Three! Paul B. Eckburg & David A. Relman Clin Infect Dis. 44:256-262 (2007) 

  11. I Wondered if Crohn’s is an Autoimmune Disease, Did I Have a Personal Genomic Polymorphism? From www.23andme.com Polymorphism in Interleukin-23 Receptor Gene— 80% Higher Risk of Pro-inflammatoryImmune Response ATG16L1 IRGM NOD2 SNPs Associated with CD Now Comparing 163 Known IBD SNPs with 23andme SNP Chip

  12. Fine Time Resolution Sampling Reveals Distinct Dynamics of Innate and Adaptive Immune System Normal Normal

  13. Four Immune Biomarkers Over TimeCompared with Four Signs/Symptoms Here Immune biomarkers are normalized 0 to 1, with 1 being the highest value in five years Source: Photo of Calit2 64-megapixel VROOM

  14. To Map My Gut Microbes, I Sent a Stool Sample to the Venter Institute for Metagenomic Sequencing Shipped Stool Sample December 28, 2011 I Received a Disk Drive April 3, 2012 With 35 GB FASTQ Files Weizhong Li, UCSD NGS Pipeline: 230M Reads Only 0.2% Human Required 1/2 cpu-yr Per Person Analyzed! Sequencing Funding Provided by UCSD School of Health Sciences  Gel Image of Extract from Smarr Sample-Next is Library Construction Manny Torralba, Project Lead - Human Genomic Medicine J Craig Venter Institute January 25, 2012

  15. CAMERA and NIH Funded Weizhong Li Group’s Metagenomic Computational NextGen Sequencing Pipeline Reads QC Raw reads HQ reads: Bowtie/BWA against Human genome and mRNAs Filter human Filtered reads CD-HIT-Dup For single or PE reads Filter duplicate Unique reads FR-HIT against Non-redundant microbial genomes Cluster-based Denoising Filter errors Read recruitment Taxonomy binning Further filtered reads Velvet, SOAPdenovo, Abyss ------- K-mer setting FRV Assemble Visualization Contigs BWA Bowtie Mapping ORF-finder Megagene Contigs with Abundance ORFs Pfam Tigrfam COG KOG PRK KEGG eggNOG tRNA-scan rRNA - HMM Cd-hit at 95% Hmmer RPS-blast blast Non redundant ORFs tRNAs rRNAs Cd-hit at 60% Core ORF clusters Cd-hit at 30% 1e-6 Function Pathway Annotation Protein families • PI: (Weizhong Li, UCSD): • NIH R01HG005978 (2010-2013, $1.1M)

  16. Additional Phenotypes Added from NIH HMPFor Comparative Analysis Download Raw Reads ~100M Per Person 35 “Healthy” Individuals 1 Point in Time 6 Ulcerative Colitis, 1 Point in Time 5 Ileal Crohn’s, 3 Points in Time

  17. We Computationally Align 230M Illumina Short Reads With a Reference Genome Set & Then Visually Analyze ~4500 Reference Genomes with Strains and Viruses

  18. From Taxonomy to Function:Analysis of LS Clusters of Orthologous Groups (COGs) Analysis: Weizhong Li & Sitao Wu, UCSD

  19. Gut Microbiome Metagenomic Analysis:From Short Reads to Taxonomic and Gene Diversity Venter Sequencing of LS Gut Microbiome: 230 M Reads 101 Bases Per Read 23 Billion DNA Bases Enabled by a Grant of Time on Gordon from SDSC Director Mike Norman • Analyzed Healthy and IBD Patients: • LS, 13 Crohn's Disease & 11 Ulcerative Colitis Patients,+ 150 HMP Healthy Subjects • Gordon Compute Time • ~1/2 CPU-Year Per Sample • > 200,000 CPU-Hours so far • Gordon RAM Required • 64GB RAM for Most Steps • 192GB RAM for Assembly • Gordon Disk Required • 8TB for All Subjects • Input, Intermediate and Final Results

  20. Phyla Gut Microbial Abundance Without Viruses: LS, Crohn’s, UC, and Healthy Subjects Source: Weizhong Li, UCSD; Calit2 FuturePatient Expedition Ulcerative Colitis LS Crohn’s Healthy Toward Noninvasive Microbial Ecology Diagnostics

  21. We Find Major Shifts in Microbial EcologyBetween Healthy and Two Forms of IBD Microbiome “Dysbiosis” or “Mass Extinction”? Explosion of Proteobacteria Collapse of Bacteroidetes On the IBD Spectrum

  22. Almost All Abundant Species (≥1%) in Healthy SubjectsAre Severely Depleted in Larry’s Gut Microbiome

  23. Top 20 Most Abundant Microbial SpeciesIn LS vs. Average Healthy Subject Number Above LS Blue Bar is Multiple of LS Abundance Compared to Average Healthy Abundance Per Species 152x 765x 148x 849x 483x 220x 201x 169x 522x Source: Sequencing JCVI; Analysis Weizhong Li, UCSD LS December 28, 2011 Stool Sample

  24. Major Changes in LS Microbiome Before and After 1 Month Antibiotic & 2 Month Prednisone Therapy Reduced 45x Reduced 90x Therapy Greatly Reduced Two Phyla, But Massive Reduction in Bacteroidetes And Large % Proteobacteria Remain Small Changes With No Therapy How Does One Get Back to a “Healthy” Gut Microbiome?

  25. LS Time Series Gut Microbiome Classesvs. Healthy, Crohn’s, Ulcerative Colitis Class Gamma-proteobacteria

  26. Does Intestinal Inflammation Select for Pathogenic Strains That Can Induce Further Damage? AIEC LF82 “Adherent-invasive E. coli (AIEC) are isolated more commonly from the intestinal mucosa of individuals with Crohn’s disease than from healthy controls.” “Thus, the mechanisms leading to dysbiosis might also select for intestinal colonization with more harmful members of the Enterobacteriaceae*—such as AIEC—thereby exacerbating inflammation and interfering with its resolution.” E. coli/Shigella Phylogenetic Tree Miquel, et al. PLOS ONE, v. 5, p. 1-16 (2010) Sebastian E. Winter , et al., EMBO reports VOL 14, p. 319-327 (2013) *Family Containing E. coli

  27. AIEC LF82 Cluster Greatly Reduced by Therapy LF82 B2 Larry Relative Abundance E. Coli/Shigella Strains At Three Times LS001 LS002 LS003 D E S Our E. coli/Shigella Phylogenetic Tree Constructed From 122 Genomes (2012) =3X 2011 Strains A B1

  28. Our New 2013 Reference Genome Set contains 761 Ecoli strains =6x our 2012 Set B2 D E B1 Colored nodes are the 38 strains in the 2011 PNAS paper A S

  29. Inflammation Enables Anaerobic Respiration Which Leads to Phylum-Level Shifts in the Gut Microbiome Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, EMBO reports VOL 14, p. 319-327 (2013)

  30. Horizontal Gene Transfer Provides Pathogenic Strains Additional Fitness Factors Leading to Growth Advantage Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, EMBO reports VOL 14, p. 319-327 (2013) Image from Zhang S., et al. Infect Immun 71: 1–12 (2003)

  31. Does the Gut Microbiome Intermediate Between Inflammation & the Development of Colorectal Cancer? The root cause of CRC is unclear, but inflammation is a well-recognized risk factor (Wu et al. 2009; McLean et al. 2011) Colon Cancer is the most common cancer among Inflammatory Bowel Disease (IBD) patients IBD is one of the three leading high-risk factors for Colon Cancer

  32. Fusobacteria Are Found To Be More Abundant In Colonrectal Carcinoma (CRC) Tissue et al. et al.

  33. LS Time Series Gut Microbiome Classesvs. Healthy, Crohn’s, Ulcerative Colitis Class Fusobacteria

  34. Distribution of Relative Species Abundance Across the Fusobacteria Phyla in LS001

  35. Class Fusobacteria Is Enriched in Human Colon Cancer Tumors “…the relative abundance of Fusobacterium was highly enriched in the population of tumor versus normal samples…” Kostic, A. D., et al. “Genomic analysis identifies association of Fusobacterium with colorectal carcinoma”, v. 22: 292–298 (2012)

  36. Could the Presence of Fusobacterium NucleatumBe an Early Indicator of a Transition to CRC? Fusobacterium nucleatum Relative AbundanceAcross LS, Healthy, UC, and CD LS Crohn’s

  37. Does Fusobacterium Have a Causal Role in the Development of Human Colorectal Cancer? “Therefore, our findings of a tumoral enrichment of Fusobacterium spp. in colorectal carcinoma suggest the possibility that these organisms may contribute to tumorigenesis, perhaps in a limited subset of patients, most conceivably by an inflammatory mediated mechanism.” “Our results do not prove a causal relationship between Fusobacterium and colorectal cancer; the establishment or repudiation of such a relationship will require further studies of colorectal cancer in both human subjects and animal models of the disease.” Kostic, A. D., et al. “Genomic analysis identifies association of Fusobacterium with colorectal carcinoma”, v. 22: 292–298 (2012)

  38. The Bacterial Driver-Passenger Model for Colorectal Cancer Initiation Is Fusobacterium nucleatum a “Driver” or a “Passenger” “Early detection of Colorectal Cancer (CRC) is one of the greatest challenges in the battle against this disease & the establishment of a CRC-associated microbiome risk profile could aid in the early identification of individuals who are at high risk and require strict surveillance.” Tjalsma, et al. Nature Reviews Microbiology v. 10, 575-582 (2012)

  39. Integrative Personal Omics ProfilingUsing 100x My Quantifying Biomarkers Cell 148, 1293–1307, March 16, 2012 • Michael Snyder, Chair of Genomics Stanford Univ. • Genome 140x Coverage • Blood Tests 20 Times in 14 Months • tracked nearly 20,000 distinct transcripts coding for 12,000 genes • measured the relative levels of more than 6,000 proteins and 1,000 metabolites in Snyder's blood

  40. Proposed UCSD/JCVIIntegrated Omics Pipeline Source: Nuno Bandiera, UCSD

  41. UCSD Center for Computational Mass SpectrometryBecoming Global MS Repository ProteoSAFe: Compute-intensive discovery MS at the click of a button MassIVE: repository and identification platform for all MS data in the world Source: Nuno Bandeira, Vineet Bafna, Pavel Pevzner, Ingolf Krueger, UCSD proteomics.ucsd.edu

  42. A “Big Data Freeway System” Connecting Users to Remote Campus Clusters & Scientific Instruments Phil Papadopoulos, SDSC, Calit2, PI

More Related